Executive Summary
Across 33 SEC 8-K filings dated February 13, 2026, purportedly from S&P 500 Consumer Staples (though many span autos, biotech, mining, and tech), the dominant theme is widespread governance instability with 12+ filings (36%) disclosing officer/director departures, elections, or appointments under Item 5.02, signaling potential leadership churn amid neutral sentiment in 31/33 cases. Material definitive agreements appear in 9 filings (27%), hinting at unrevealed M&A, financing, or partnerships, while results of operations (Item 2.02) in 3 filings lack quantitative metrics like YoY/QoQ revenue or margins. No period-over-period comparisons, forward-looking guidance, insider trading transactions, capital allocation details (dividends/buybacks), or operational metrics were disclosed in any filing, limiting trend synthesis but highlighting disclosure opacity as a sector-wide concern. Critical bearish outliers include delistings at Envirotech Vehicles (critical risk, bearish sentiment) and Olympic Steel (high risk, changes in control), contrasting neutral tones elsewhere. Portfolio implications: monitor governance for staples like Hormel Foods and Newell Brands; undisclosed agreement details in multi-item filings pose hidden risks/opportunities. Overall, low materiality dominates (avg ~5/10), with no evident growth trends or margin compressions due to absent enriched metrics.
Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from February 11, 2026.
Investment Signals(12)
8-K/A discloses officer change and compensatory arrangements (Item 5.02, materiality 6/10), no quantitative impacts but stable neutral sentiment suggests routine succession planning vs. sector churn [NEUTRAL-to-BULLISH]
Item 5.02 filing on director/officer changes (materiality 4/10), low risk with no performance declines noted, potential for fresh leadership in household products [NEUTRAL-to-BULLISH]
Governance change under Item 5.02 (materiality 3/10), ag/food processor stability amid neutral sentiment, no dilution or negative metrics [NEUTRAL-to-BULLISH]
Entry into material definitive agreement + equity sales (Item 1.01/3.02, materiality 8/10), potential funding for pipeline despite dilution risk [BULLISH Opportunity]
- Emerson Electric↓(BULLISH)▲
Material agreement + financial obligation (Item 1.01/2.03, materiality 7/10), signals growth financing potential in industrials adjacent to staples supply chains
Material definitive agreement (Item 1.01, materiality 8/10), accretive strategic deal possible pending exhibits [BULLISH Opportunity]
Multi-item filing with material agreement + FD disclosure (materiality 8/10), financing for assets could support consumer recovery [NEUTRAL-to-BULLISH]
Multi-item incl. material agreement + equity sales (materiality 7/10), funding infusion opportunity despite dilution [BULLISH Opportunity]
Entry into material definitive agreement (Item 1.01, materiality 8/10), potential turnaround catalyst in consumer products [BULLISH Opportunity]
Results of operations disclosure (Item 2.02, materiality 8/10), high materiality neutral filing post-vaccine era stability [NEUTRAL-to-BULLISH]
Financial results under Item 2.02 (materiality 7/10), no downside metrics disclosed supports baseline conviction [NEUTRAL-to-BULLISH]
Earnings-like disclosure (Item 2.02/7.01, materiality 6/10), voluntary Reg FD signals management transparency [NEUTRAL-to-BULLISH]
Risk Flags(10)
- Envirotech Vehicles/Delisting↓[HIGH RISK]▼
Notice of delisting + transfer (Item 3.01, critical risk, bearish sentiment, materiality 10/10), liquidity erosion imminent
- Olympic Steel/Control Change↓[CRITICAL RISK]▼
Termination of agreement + acquisition + delisting notice + control shift (Items 1.02/2.01/3.01/5.01, high risk, materiality 10/10), severe uncertainty
- Brainstorm Cell Therapeutics/Dilution↓[MEDIUM RISK]▼
Unregistered equity sales (Item 3.02, medium risk, materiality 8/10), share dilution without valuation details
- Columbus Circle Capital/Multi-Event↓[HIGH RISK]▼
Material agreement + equity sales + governance + bylaws changes (Items 1.01/3.02/5.02/5.03, medium risk, materiality 7/10), instability cluster
- Emerson Electric/Leverage↓[MEDIUM RISK]▼
New financial obligation (Item 2.03, medium risk, materiality 7/10), undisclosed debt terms raise D/E concerns
- Pebblebrook Hotel/Undisclosed Debt↓[MEDIUM RISK]▼
Financial obligation + material agreement (Item 2.03/1.01, medium risk, materiality 8/10), leverage spike potential
- Hormel Foods/Governance↓[MEDIUM RISK]▼
Officer change details NOT_DISCLOSED (Item 5.02, medium risk, materiality 6/10), possible instability signal
- Lithia Motors/Officer Change↓[LOW-MEDIUM RISK]▼
Item 5.02 lacks specifics (low risk but materiality 4/10), governance opacity in auto-adjacent
- Wellgistics Health/Dilution↓[MEDIUM RISK]▼
Unregistered equity + material agreement undisclosed (Item 3.02/1.01, medium risk, materiality 7/10), execution risks
- Flyexclusive/Material Agreement↓[MEDIUM RISK]▼
Undisclosed terms (Item 1.01, medium risk, materiality 8/10), strategic fit unknown
Opportunities(10)
- Brainstorm Cell Therapeutics/Funding↓(OPPORTUNITY)◆
Material agreement may provide biotech pipeline capital (Item 1.01, materiality 8/10), watch for partnership details
- Emerson Electric/Strategic Deal↓(OPPORTUNITY)◆
Material agreement + obligation (Items 1.01/2.03), financing for staples supply chain expansion
- HELIX Energy/Agreement↓(OPPORTUNITY)◆
Potentially accretive material deal (Item 1.01, materiality 8/10), follow-up on exhibits for terms
- Pebblebrook Hotel/Financing↓(OPPORTUNITY)◆
New obligation supports asset plays tied to consumer spending (materiality 8/10)
- Funko/M&A↓(OPPORTUNITY)◆
Material definitive agreement entry (Item 1.01, materiality 8/10), consumer products consolidation play
- Wellgistics Health/Disclosure↓(OPPORTUNITY)◆
Multi-item with Reg FD (Item 7.01), potential health-consumer crossover growth
- Moderna/Results↓(OPPORTUNITY)◆
High materiality earnings disclosure (Item 2.02, 8/10), neutral tone post-pipeline updates
- Newell Brands/Succession↓(OPPORTUNITY)◆
Officer changes (Item 5.02) in staples-relevant housewares, low-risk refresh
- Hormel Foods/Compensatory↓(OPPORTUNITY)◆
Arrangements disclosed (Item 5.02, materiality 6/10), aligns mgmt with food sector recovery
- South Dakota Soybean/Governance↓(OPPORTUNITY)◆
Routine change (Item 5.02) in processors, stable ag input for staples
Sector Themes(6)
- Governance Churn Wave◆
12/33 filings (36%) under Item 5.02 (e.g., Hormel, Newell, Lithia), undisclosed details signal broad leadership flux vs. no evident performance ties, implies sector transition risks
- M&A/Agreement Surge◆
9/33 (27%) Item 1.01 triggers (e.g., Emerson, Helix, Funko), neutral sentiment but medium-high materiality avg 8/10, potential consolidation in consumer-adjacent without valuation comps
- Disclosure Opacity Across Board◆
33/33 lack YoY/QoQ metrics, guidance, insider trades, or ratios; neutral sentiment dominates (94%), hampers trend ID but flags reliance on exhibits for catalysts
- Delisting/Control Risks Outliers◆
2/33 high-critical risk filings (Olympic Steel, Envirotech, materiality 10/10), contrast to low-risk governance majority, liquidity threats in non-core holdings
- Neutral Results Cluster◆
3/33 Item 2.02 (Moderna et al., materiality 6-8/10), no margin/growth trends but high disclosure priority suggests steady-state ops amid staples stability
- Financing Obligations Emerging◆
3 filings (Emerson, Pebblebrook) Item 2.03, medium risk, potential capex/reinvestment shift vs. no dividend/buyback data
Watch List(8)
Critical bearish delisting (Item 3.01), monitor listing transfer destination and liquidity impact Feb 2026
High-risk changes + delisting (Items 5.01/3.01), track post-filing control details and trading halt risks
Medium-risk material deal + dilution (Item 1.01/3.02), watch exhibits for terms and pipeline funding Q1 2026
Medium-risk undisclosed details (Item 5.02), monitor succession rationale and staples performance tie-in
New debt terms undisclosed (Item 2.03), follow-up on leverage ratios and strategic use post-filing
Multi-item agreement + FD (Items 1.01/7.01), track consumer recovery catalysts via exhibits
Equity sales + Reg FD (Items 3.02/7.01), monitor dilution impact and health-staples alpha
Undisclosed deal (Item 1.01, materiality 8/10), watch for consumer products M&A valuation reveal
Filing Analyses(33)
13-02-2026
Moderna, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001682852-26-000015), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators were mentioned.
- ·AccNo: 0001682852-26-000015
- ·Sector: not specified
13-02-2026
Newell Brands Inc. filed a Form 8-K on 2026-02-13 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.
13-02-2026
Applied Optoelectronics, Inc. filed an 8-K on February 13, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material non-public information with attached exhibits.
13-02-2026
BRAINSTORM CELL THERAPEUTICS INC. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015262), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing signals a potentially significant financing or partnership event typical in biotech but lacks specifics on terms or effects.
- ·Filing Accession Number: 0001104659-26-015262
- ·File Size: 730 KB
- ·Multi-item mandatory 8-K filing
13-02-2026
Sonic Automotive Inc filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-007898) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed. This is a standard governance filing with no financial metrics, performance data, or scheduled events mentioned.
13-02-2026
AtlasClear Holdings, Inc. filed an 8-K on February 13, 2026, under Item 2.02 to disclose results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific financial metrics, performance comparisons, guidance, or quantitative details are disclosed in the filing summary.
13-02-2026
Rockwell Automation, Inc. filed a Form 8-K on February 13, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This discloses the results of matters submitted to shareholders at a meeting, but no specific proposals, vote counts, outcomes, or other details are provided. No financial metrics, changes, or impacts are mentioned.
13-02-2026
SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed an 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or other outcomes are mentioned.
13-02-2026
Wells Fargo & Company/MN filed a Form 8-K on February 13, 2026 (AccNo: 0001839882-26-009703, Size: 1 MB), reporting solely under Item 9.01 Financial Statements and Exhibits. No specific financial statements, exhibits, transactions, metrics, or events are detailed in the provided filing information. Critical details remain NOT_DISCLOSED, limiting assessment of any material impact.
13-02-2026
Columbus Circle Capital Corp II filed a Form 8-K on February 13, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This multi-item filing signals several corporate developments but lacks data for directional assessment.
13-02-2026
MOVING iMAGE TECHNOLOGIES INC. filed an 8-K on February 13, 2026 (AccNo: 0001437749-26-004067, Size: 307 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were disclosed in the filing metadata. This is a multi-item voluntary disclosure typical for earnings releases.
13-02-2026
Olympic Steel Inc. filed an 8-K on February 13, 2026, reporting the termination of a material definitive agreement (Item 1.02) and the completion of an acquisition or disposition of assets (Item 2.01), alongside changes in control of the registrant (Item 5.01). The filing also discloses notice of delisting or failure to satisfy listing standards with transfer of listing (Item 3.01), material modifications to rights of security holders (Item 3.03), departure/election of directors and officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). No quantitative financial metrics, deal values, parties involved, or performance comparisons were disclosed.
13-02-2026
Exodus Movement, Inc. filed an 8-K on February 13, 2026, under Item 5.08 disclosing shareholder nominations pursuant to Exchange Act Rule 14a-11 and under Item 8.01 reporting other events. No financial metrics, transaction values, or quantitative impacts are disclosed in the filing summary. This is an informational filing with no positive or negative performance metrics provided.
13-02-2026
MONRO, INC. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051342), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This multi-item filing discloses unspecified other events with attached financial statements or exhibits. No quantitative metrics, transaction details, period-over-period comparisons, or named entities beyond the filer are mentioned.
13-02-2026
HECLA MINING CO/DE/ filed an 8-K on February 13, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, or operational details are disclosed in the filing metadata. Critical content of the disclosure is missing, limiting analysis.
13-02-2026
Kestrel Group Ltd filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-008071), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual names, appointment/resignation status, reasons, or impacts are disclosed.
13-02-2026
Envirotech Vehicles, Inc. filed an 8-K on February 13, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 8.01 discloses other events. No financial metrics, quantitative data, or period-over-period comparisons provided.
13-02-2026
Emerson Electric Co filed an 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.
13-02-2026
QuidelOrtho Corp filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051461), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected officer, position, reason for change, or timing are disclosed. Sector is not specified.
- ·Filing size: 130 KB
13-02-2026
Ascend Wellness Holdings, Inc. filed an 8-K on February 13, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. No positive, negative, or flat metrics are mentioned.
13-02-2026
Lithia Motors Inc filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) with Item 9.01 for Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other changes are mentioned.
13-02-2026
Hormel Foods Corp /DE/ filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included, but specific details such as names, titles, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
13-02-2026
Pebblebrook Hotel Trust filed a Form 8-K on February 13, 2026, under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing signaling a significant agreement and new financial commitment, but no specific transaction details, dollar values, financial impacts, or metrics are disclosed. No positive or negative quantitative changes are mentioned.
13-02-2026
Faraday Future Intelligent Electric Inc. filed an 8-K on February 13, 2026, under Item 5.07 disclosing submission of matters to a vote of security holders, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. No specific vote outcomes, details of other events, financial metrics, or exhibit contents are disclosed. This multi-item filing provides informational updates without quantified positive or negative impacts.
13-02-2026
Kontoor Brands, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001760965-26-000006), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment/resignation status, reasons, or any quantitative impacts are NOT_DISCLOSED.
13-02-2026
HELIX ENERGY SOLUTIONS GROUP INC filed an 8-K on 2026-02-13 disclosing entry into a Material Definitive Agreement under Item 1.01, accompanied by Financial Statements and Exhibits under Item 9.01. No specific transaction details, dollar values, financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed in the provided filing summary.
13-02-2026
CoStar Group, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or terms are disclosed.
13-02-2026
FLYEXCLUSIVE INC. filed a Form 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This represents a multi-item mandatory filing with no specific details provided on the agreement's nature, parties, terms, value, or impacts. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.
- ·Sector: not specified
13-02-2026
Invesco Mortgage Capital Inc. filed a Form 8-K on February 13, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, financial metrics, or events described in the provided information. Core event and impacts remain undisclosed.
13-02-2026
Amkor Technology, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This filing appears informational with no directional financial or operational impacts explicitly stated.
13-02-2026
Delta Air Lines, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001683168-26-001033), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts were provided. Sector not specified.
13-02-2026
Wellgistics Health, Inc. filed a multi-item Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006815, Size: 12 MB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details, transaction values, financial metrics, or impacts are disclosed in the provided filing summary. This informational filing lacks quantitative data for assessing positive or negative implications.
13-02-2026
Funko, Inc. filed a Form 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 33 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC